DOTTIKON ES HOLDING AG-REG
DOTTIKON ES HOLDING AG-REG/ CH0582581713 /
DESN/Z
8/15/2024 5:12:52 PM
|
Chg.
-0.75
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
258.75CHF
|
-0.29%
|
75 Turnover: 19,460.50 |
-Bid Size: - |
-Ask Size: - |
3.89 bill.CHF |
- |
44.09 |
Business description
Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioning itself as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative uses of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. The technology portfolio is built around active pharmaceutical ingredients (APIs) and performance chemicals and comprises hazardous reactions, low-temperature and high-pressure reactions as well as continuous processing.
Management board & Supervisory board
CEO |
Dr. Markus Blocher |
Management board |
Marlene Born, Karin Krause, Dr. Stephan Kirschbaum, Dr. Urs Brändli, Dr. Thomas Rosatzin, Dr. Robert Dahinden, Dr. Rolf Schaller |
Supervisory board |
Dr. Markus Blocher, Dr. Pierre-Alain Ruffieux, Dr. Bernhard Urwyler |
Company data
Name: |
Dottikon ES Holding AG |
Address: |
Hembrunnstrasse 17,CH-5605 Dottikon |
Phone: |
+41-56-616-8111 |
Fax: |
- |
E-mail: |
info@dottikon.com
|
Internet: |
www.dottikon.com |
Industry: |
Commodities |
Sector: |
Chemicals |
Sub sector: |
- |
End of financial year: |
3/31 |
Free Float: |
16.20% |
IPO date: |
- |
Company calendar
CW 48 | 11/29/2024
Interim Report 2nd Quarter/6 Months
|